NDC 73540-003

Yakkongmo treatment

Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin

Yakkongmo treatment is a Topical Liquid in the Human Otc Drug category. It is labeled and distributed by Bobsnu Co., Ltd.. The primary component is Salicylic Acid; Pyrithione Zinc; Dexpanthenol.

Product ID73540-003_9f273fc5-32f9-a1b9-e053-2995a90aa870
NDC73540-003
Product TypeHuman Otc Drug
Proprietary NameYakkongmo treatment
Generic NamePyrithione Zinc, Dexpanthenol, Niacinamide, Biotin
Dosage FormLiquid
Route of AdministrationTOPICAL
Marketing Start Date2020-02-22
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameBOBSNU CO., LTD.
Substance NameSALICYLIC ACID; PYRITHIONE ZINC; DEXPANTHENOL
Active Ingredient Strength0 g/100mL; g/100mL; g/100mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 73540-003-01

200 mL in 1 TUBE (73540-003-01)
Marketing Start Date2020-02-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 73540-003-01 [73540000301]

Yakkongmo treatment LIQUID
Marketing Categoryunapproved drug other
Product TypeHUMAN OTC DRUG
Marketing Start Date2020-02-22

Drug Details

Active Ingredients

IngredientStrength
SALICYLIC ACID.2 g/100mL

NDC Crossover Matching brand name "Yakkongmo treatment" or generic name "Pyrithione Zinc, Dexpanthenol, Niacinamide, Biotin"

NDCBrand NameGeneric Name
73540-003Yakkongmo treatmentpyrithione zinc, dexpanthenol, niacinamide, biotin
73540-001Yakkongmo scalp deep cleansingshampoopyrithione zinc, dexpanthenol, niacinamide, biotin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.